CRISPR gene therapy for sickle cell disease and β-thalassemia gets UK approval

United Kingdom approves first-ever CRISPR treatment, a cure for sickle cell disease and beta thalassemia

Sickle cell CRISPR 'cure' is the start of a revolution in medicine

One-time CRISPR treatment could permanently lower cholesterol